NXTC NextCure
- 1.600
- 0.0000.00%
NextCure News
NextCure | 10-Q: Quarterly report
NextCure | 8-K: NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
NextCure | DEF 14A: Definitive information statements
NextCure | DEFA14A: Others
NextCure | PRE 14A: Preliminary proxy statements relating to merger or acquisition
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Shaw Kevin G.
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Richman Michael
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Mayer Timothy
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Myint Han
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Langermann Sol
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Kundu Sourav
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Cobourn Steven P.
NextCure | SC 13G: Statement of acquisition of beneficial ownership by individuals-Logos Global Management LP(7.2%),Logos Global Management GP LLC(7.2%), etc.
NextCure | 10-K: Annual report
NextCure | 8-K: Current report
NextCure | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(4.5%),OrbiMed Capital GP VI LLC(4.5%)
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Langermann Sol
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Mayer Timothy
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Myint Han
NextCure | 4: Statement of changes in beneficial ownership of securities-Officer Richman Michael
Analysis
Price Target
No Data
